Home | Articles
Published on:April 2016
Indian Journal of Pharmaceutical Education and Research, 2016; 50(2s):S168-S179
Pharmaceutical Research | doi:10.5530/ijper.50.2.33

Development of Novel lipid Nanoparticles for oral Bioavailability Enhancement of Irinotecan: In-vitro and In-vivo Investigations


Authors and affiliation (s):

Zulfiqar Ahmad1, Sushama Talegaonkar1*, Mohammad Tariq1, Lalit Mohan Negi2, Farhan Jalees Ahmad1

1Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, 110062, INDIA.

2Department of Oncology , Fresenius Kabi Pvt. Ltd, Gurgaon, Haryana, INDIA.

Abstract:

Background: Irinotecan is indicated as a first line treatment for metastatic colorectal cancer. However, chemotherapy with irinotecan is restricted to i.v. route owing to poor and erratic oral bioavailability due to its excessive intestinal efflux by P-glycoprotein. Objective: Aim of the present study is to improve the oral pharmacokinetic profile of irinotecan (IRT) by merging the attributes of nano-particulate system and P-glycoprotein (P-gp) modulation activity of excipients. Methods: Gelucire 44/14 solid lipid nanoparticles (SLN) were developed and optimized by Box- Behnken design. Optimized formulation was evaluated for various in vitro attributes and in vivo pharmacokinetic profile. Results: Size of optimized SLN was found to be 179.8±15.3 nm with polydispersity index, 0.367±0.029 and drug entrapment, 78.2±4.6%. SLN showed biphasic release profile i.e. initial burst release followed by sustained release. Differential scanning calorimetric (DSC) and X-ray diffractometric (XRD) analyses of SLN demonstrated the loss of drug’s crystallinity in SLN. Further, confocal laser scanning microscopy showed higher permeation of Rhodamine 123 (P-gp substrate) across intestinal epithelium through SLN when compared with free rhodamine 123 solution. Furthermore, in-vivo studies exhibited superior pharmacokinetic profile; significantly high (p<0.001) Cmax (1471.6±190.9 ng/mL) was attained through SLN when compared with Cmax of oral suspension (1113.5±125.5 ng/mL), similarly, high Tmax (p<0.001) was observed which revealed sustained effect of SLN. Conclusively, 2.79 folds improvement in oral bioavailability of IRT could be achieved through SLN when compared with oral suspension. Conclusion: Outcomes of studies suggested the potential of developed SLN for oral delivery of irinotecan and possibility to replace pre-existing intravenous therapy.

Key words: Gelucire 44/14, Lipid nanocarrier, Intestinal gut sac method, Pharmacokinetic study.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs